Is a complete MAZE research report available?

No complete published report is available for Maze Therapeutics, Inc. (MAZE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Maze Therapeutics, Inc. (MAZE)

NASDAQ: MAZE · USD

$31.8

+0.12 (+0.4%)· Recorded snapshot

Market cap	1.8B
Revenue (ttm)	20M
Net income (ttm)	-133.6M
EPS (ttm)	-$2.52
Shares out	55.5M
Volume	325,622

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 20M
Net income (ttm): -133.6M
EPS (ttm): -$2.52
Market cap: 1.8B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Conserver

Metric	Value
Amount currency	USD
CIK code	0001842295
Company name	Maze Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	578784100
Earnings date	2026-11-09
Earnings time	amc
Employees	141
Employees change	16
Employees growth	12.8%
Enterprise value	$1.3B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2025-01-31
Is primary listing	Yes
Is SPAC	No
ISIN number	US5787841007
Last 10-K release date	2026-03-25
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.8B
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$31.81
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	MAZE
U.S. state	California
Website	https://www.mazetx.com

Metric

Value

Amount currency

USD

CIK code

0001842295

Company name

Maze Therapeutics, Inc.

Country

United States

Country code

CUSIP number

578784100

Earnings date

2026-11-09

Earnings time

amc

Employees

141

Employees change

Employees growth

12.8%

Enterprise value

$1.3B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2018

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2025-01-31

Is primary listing

Yes

Is SPAC

ISIN number

US5787841007

Last 10-K release date

2026-03-25

Last earnings date

2026-08-11

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$1.8B

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$31.81

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

MAZE

U.S. state

California

Website

https://www.mazetx.com

Metric	Value
Earnings yield	-7.91%
EV/Sales	65.57x
FCF / EV yield	-8.15%
FCF yield	-6.12%
Forward EV/Sales	290.71x
Forward P/S	387.02x
P/B ratio	3.88x
P/S ratio	87.3x
Price / tangible book value	3.85x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-7.91%

EV/Sales

65.57x

FCF / EV yield

-8.15%

FCF yield

-6.12%

Forward EV/Sales

290.71x

Forward P/S

387.02x

P/B ratio

3.88x

P/S ratio

87.3x

Price / tangible book value

3.85x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Gross margin	100%
Operating margin	-728.06%
Pretax margin	-667.95%
Profit per employee	$-947,447
Revenue per employee	$141,844
ROA	-21.79%
ROCE	-28.63%
ROE	-37.35%
ROIC	-190.34%
SBC / revenue	131.17%

Metric

Value

Gross margin

100%

Operating margin

-728.06%

Pretax margin

-667.95%

Profit per employee

$-947,447

Revenue per employee

$141,844

ROA

-21.79%

ROCE

-28.63%

ROE

-37.35%

ROIC

-190.34%

SBC / revenue

131.17%

Metric	Value
EPS growth quarters	4
EPS growth years	0
Gross profit growth	700%
Net income growth years	0
Revenue growth	700%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

700%

Net income growth years

Revenue growth

700%

Revenue growth years

Metric	Value
Capital expenditures	$-302,000
Depreciation and amortization	$1.9M
EBIT	$-145.6M
EBITDA	$-143.7M
EPS	$-2.52
FCF per share	$-1.92
Financing cash flow	$337.1M
Free cash flow	$-106.8M
Free cash flow minus SBC	$-133.1M
Gross profit	$20M
Investing cash flow	$-292.5M
Net borrowing	$39.4M
Net cash flow	$-61.9M
Net income	$-133.6M
Operating cash flow minus SBC	$-132.8M
Operating income	$-145.6M
Revenue	$20M
Stock-based compensation	$26.2M

Metric

Value

Capital expenditures

$-302,000

Depreciation and amortization

$1.9M

EBIT

$-145.6M

EBITDA

$-143.7M

EPS

$-2.52

FCF per share

$-1.92

Financing cash flow

$337.1M

Free cash flow

$-106.8M

Free cash flow minus SBC

$-133.1M

Gross profit

$20M

Investing cash flow

$-292.5M

Net borrowing

$39.4M

Net cash flow

$-61.9M

Net income

$-133.6M

Operating cash flow minus SBC

$-132.8M

Operating income

$-145.6M

Revenue

$20M

Stock-based compensation

$26.2M

Metric	Value
Altman Z-Score	9.75
Book value per share	$8.16
Debt / equity	0.13
Interest coverage	-81.03
Long-term assets	$111.2M
Long-term liabilities	$55.5M
Net cash (debt)	$434.5M
Net cash / market cap	24.89%
Net cash growth	81.39%
Net debt / equity	-0.96
Piotroski F-Score	3
Property, plant and equipment	$22.8M
Shareholders' equity	$453.1M
Tangible book value	$453.1M
Tangible book value per share	$8.16
Total assets	$531.6M
Total cash	$411.1M
Total debt	$60.4M
Total liabilities	$78.5M

Metric

Value

Altman Z-Score

9.75

Book value per share

$8.16

Debt / equity

0.13

Interest coverage

-81.03

Long-term assets

$111.2M

Long-term liabilities

$55.5M

Net cash (debt)

$434.5M

Net cash / market cap

24.89%

Net cash growth

81.39%

Net debt / equity

-0.96

Piotroski F-Score

Property, plant and equipment

$22.8M

Shareholders' equity

$453.1M

Tangible book value

$453.1M

Tangible book value per share

$8.16

Total assets

$531.6M

Total cash

$411.1M

Total debt

$60.4M

Total liabilities

$78.5M

Metric	Value
Asset turnover	0.05
Current assets	$420.4M
Current liabilities	$23M
Current ratio	18.31
Net working capital	$-8.7M
Quick ratio	18.03
Working capital	$397.5M
Working capital turnover	0.06

Metric

Value

Asset turnover

0.05

Current assets

$420.4M

Current liabilities

$23M

Current ratio

18.31

Net working capital

$-8.7M

Quick ratio

18.03

Working capital

$397.5M

Working capital turnover

0.06

Metric	Value
Buyback yield / dilution	-174.46%
Dividend yield	0%
Shareholder yield	-174.46%

Metric

Value

Buyback yield / dilution

-174.46%

Dividend yield

Shareholder yield

-174.46%

Metric	Value
150-day SMA	$27.30
1D price change	0.38%
1M price change	21.23%
1M total return	21.23%
1W price change	-2.68%
1W total return	-2.68%
1Y price change	1.87%
1Y return CAGR	1.87%
1Y total return	1.87%
20-day SMA	$28.64
200-day SMA	$31.95
3M price change	10.07%
3M total return	10.07%
50-day SMA	$27.40
50-day SMA vs 200-day SMA	50under200
52-week high	$53.65
52-week high date	2026-03-16
52-week low	$21.95
52-week low date	2026-09-21
6M price change	19.31%
6M total return	19.31%
All-time high	$53.65
All-time high date	2026-03-16
All-time low	$6.71
All-time low date	2025-04-09
Average true range (ATR)	$1.59
Average volume	794.7K
Beta (1Y)	0.87
Beta (2Y)	0.96
Change from 52-week high	-40.71%
Change from 52-week low	44.92%
Change from all-time high	-41.14%
Change from all-time low	370.64%
Change from open	1.63%
Day's gap	-1.23%
Dollar volume	$10.4M
High price	$31.83
Low price	$31.26
Monthly RSI	50.9
Open price	$31.30
Position in 52-week range	96.49%
Premarket change	0%
Premarket close	$31.69
Premarket price	$31.69
Premarket volume	200
Previous close	$31.69
Price vs 150-day SMA	15.69%
Price vs 20-day SMA	10.27%
Price vs 200-day SMA	-1.15%
Price vs 50-day SMA	15.27%
Relative volume	0.41
Return from IPO open	94.98%
Return from IPO price	96.44%
RSI	64.91
Sharpe ratio	0.33
Sortino ratio	0.54
Volume	325.6K
Weekly RSI	56.27
YTD price change	-23.78%
YTD total return	-23.78%

Metric

Value

150-day SMA

$27.30

1D price change

0.38%

1M price change

21.23%

1M total return

21.23%

1W price change

-2.68%

1W total return

-2.68%

1Y price change

1.87%

1Y return CAGR

1.87%

1Y total return

1.87%

20-day SMA

$28.64

200-day SMA

$31.95

3M price change

10.07%

3M total return

10.07%

50-day SMA

$27.40

50-day SMA vs 200-day SMA

50under200

52-week high

$53.65

52-week high date

2026-03-16

52-week low

$21.95

52-week low date

2026-09-21

6M price change

19.31%

6M total return

19.31%

All-time high

$53.65

All-time high date

2026-03-16

All-time low

$6.71

All-time low date

2025-04-09

Average true range (ATR)

$1.59

Average volume

794.7K

Beta (1Y)

0.87

Beta (2Y)

0.96

Change from 52-week high

-40.71%

Change from 52-week low

44.92%

Change from all-time high

-41.14%

Change from all-time low

370.64%

Change from open

1.63%

Day's gap

-1.23%

Dollar volume

$10.4M

High price

$31.83

Low price

$31.26

Monthly RSI

50.9

Open price

$31.30

Position in 52-week range

96.49%

Premarket change

Premarket close

$31.69

Premarket price

$31.69

Premarket volume

200

Previous close

$31.69

Price vs 150-day SMA

15.69%

Price vs 20-day SMA

10.27%

Price vs 200-day SMA

-1.15%

Price vs 50-day SMA

15.27%

Relative volume

0.41

Return from IPO open

94.98%

Return from IPO price

96.44%

RSI

64.91

Sharpe ratio

0.33

Sortino ratio

0.54

Volume

325.6K

Weekly RSI

56.27

YTD price change

-23.78%

YTD total return

-23.78%

Metric	Value
Float	36.8M
Float percentage	66.24%
Shares change (QoQ)	9.46%
Shares change (YoY)	174.46%
Shares held by insiders	0.8%
Shares held by institutions	73.66%
Shares outstanding	55.5M
Short % of float	20.46%
Short % of shares	13.55%
Short ratio	7.9 days

Metric

Value

Float

36.8M

Float percentage

66.24%

Shares change (QoQ)

9.46%

Shares change (YoY)

174.46%

Shares held by insiders

0.8%

Shares held by institutions

73.66%

Shares outstanding

55.5M

Short % of float

20.46%

Short % of shares

13.55%

Short ratio

7.9 days

Maze Therapeutics, Inc. (MAZE)

Price

Financial snapshot

Fair-value bridge

Latest news · MAZE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MAZE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MAZE

Frequently asked questions